Skip to content

Noninvasive Measurement of the Cerebral Autoregulation in Neonates and Infants With Complex Congenital Heart Disease

Noninvasive Measurement of the Cerebral Autoregulation in Neonates and Infants With Complex Congenital Heart Disease After Cardiac Surgery With Cardiopulmonary Bypass at the Pediatric Intensive Care Unit (PICU)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04810013
Enrollment
80
Registered
2021-03-22
Start date
2020-06-01
Completion date
2023-11-30
Last updated
2023-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complex Congenital Heart Disease

Brief summary

Feasibility of non-invasive cerebral autoregulation measurement at the PICU and impact of changes in oxygen supply

Detailed description

Cerebral protection is a major issue in the treatment of neonates and infants with complex congenital heart disease, because most common long-term morbidities of newborn heart surgery are related not to the heart, but instead to the cognitive challenges experienced by this population. Disruption of cerebral autoregulation in the postoperative period may contribute to brain injury in these patients. Blood pressure management, respirator management and red blood cell transfusion management after cardiopulmonary bypass surgery using endpoints such cerebral autoregulation monitoring might provide a method to optimize organ perfusion and improve neurologic outcome from cardiac surgery in the vulnerable postoperative period. Primary Objectives: Feasibility of non-invasive cerebral autoregulation measurement at the PICU: Identification of the range of mean arterial blood pressure (MAP) with optimal vasoreactivity (MAPOPT), indicating intact cerebral autoregulation. Secondary Objectives: Impact of decreased oxygen delivery, increased cerebral oxygen extraction, decreased cardiac output, arterial hypotension, severe hypoxemia and/or severe anemia on cerebral autoregulation.

Interventions

PROCEDUREnon-invasive measurement of cerebral autoregulation

Non-invasive measurement of the cerebral autoregulation in the postoperative period in 80 neonates and infants with complex congenital heart disease undergoing cardiopulmonary bypass surgery. A continuous, moving Pearson's correlation coefficient will be calculated between the arterial pressure and near-infrared spectroscopy signals and displayed continuously during surgery using a laptop computer and the ICM+ software (Cambridge Enterprise).

Sponsors

University Hospital Tuebingen
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 1 Months
Healthy volunteers
No

Inclusion criteria

* term (37-42 weeks gestation) newborns * pre- or postnatally diagnosed critical congenital heard disease (CHD) * admitted to the pediatric cardiac intensive care unit at the Children's Hospital of Tübingen

Exclusion criteria

* birth weight \<2 kg * history of neonatal depression (5-min APGAR\<5, cord blood pH\<7.0, sepsis, or birth asphyxia) * perinatal seizures * evidence of end-organ injury * preoperative cardiac arrest * significant preoperative intracerebral hemorrhage such as grade 3 or 4 intraventricular hemorrhage.

Design outcomes

Primary

MeasureTime frameDescription
Range of mean arterial blood pressure4within 8 hours after cardiac surgery at the PICUMeasurement of the range of mean arterial blood pressure (MAP) with optimal vasoreactivity (MAPOPT)

Secondary

MeasureTime frameDescription
Neurological outcome measureat age of 2 yearsLandmarks of development score (Grenzsteine der Entwicklung Score) aus (Monatsschr Kinderheilkd\_2013 · 161:898-910\_· DOI 10.1007/s00112-012-2751-0 © Springer-Verlag Berlin Heidelberg 2013 R.\_Michaelis\_· R.\_Berger\_· U.\_Nennstiel-Ratzel\_· I.\_Krägeloh-Mann Validierte und teilvalidierte Grenzsteine der Entwicklung). The score uses dichotomous questions, that asks for a Yes/No response. The score consists of a total of 16 questions, the more questions answered yes, the better the outcome and vice versa. Minimum value is n=0 yes and n=16 no answers, maximum value is n=16 yes and n=0 no answers.
Influence of changed fractional cerebral oxygen extraction (cFTOE) on cerebral autoregulationwithin 8 hours after cardiac surgery at the PICUAnalysis of the influence of changed fractional cerebral oxygen extraction (cFTOE) on cerebral autoregulation.Association between cFTOE and cerebral autoregulation indices (COx and HVx).
Detection of severe brain injurybefore surgery, 12 hours, 48 hours, 72 hours post surgery and before dischargeDetection of cerebral haemorrhage grade III or IV, cystic periventricular leukomalacia, cerebellar haemorrhage, post-haemorrhagic ventricular dilatation or cerebral atrophy) on routinely performed serial cranial ultrasound scans
Influence of changed arterial oxygen saturation on cerebral autoregulationwithin 8 hours after cardiac surgery at the PICUAnalysis of the influence of changed arterial oxygen saturation on cerebral autoregulation. Association between arterial SPO2 (%) and cerebral autoregulation indices (COx and HVx).
Influence of changed blood hemoglobin concentration on cerebral autoregulationwithin 8 hours after cardiac surgery at the PICU4\. Analysis of the influence of changed blood hemoglobin concentration on cerebral autoregulation. Association between arterial hemoglobin value (g/dL) and cerebral autoregulation indices (COx and HVx).
Influence of changed arterial blood pressure on cerebral autoregulationwithin 8 hours after cardiac surgery at the PICUAnalysis of the influence of changed arterial blood pressure on cerebral autoregulation. Association between arterial blood pressure (mmHg) and cerebral autoregulation indices (COx and HVx).

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026